Surgery Partners (NASDAQ:SGRY) Stock Rating Lowered by Zacks Research

Surgery Partners (NASDAQ:SGRY) was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

SGRY has been the topic of several other research reports. Benchmark reiterated a “buy” rating on shares of Surgery Partners in a research note on Tuesday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a report on Tuesday, May 26th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $18.00 target price on shares of Surgery Partners in a research note on Tuesday. Raymond James Financial set a $18.00 price target on shares of Surgery Partners in a report on Tuesday. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $17.00 price target on shares of Surgery Partners in a research note on Wednesday, May 6th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $19.45.

Surgery Partners Trading Down 6.0%

Shares of Surgery Partners stock opened at $15.00 on Monday. The firm’s 50-day moving average price is $15.51 and its two-hundred day moving average price is $14.43. The company has a market capitalization of $1.96 billion, a price-to-earnings ratio of -21.43, a PEG ratio of 4.77 and a beta of 1.91. The company has a quick ratio of 1.69, a current ratio of 1.86 and a debt-to-equity ratio of 1.17. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $24.10.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.87%. The business had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. During the same quarter last year, the business posted $0.17 EPS. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, analysts forecast that Surgery Partners will post 0.25 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Surgery Partners

Several institutional investors and hedge funds have recently added to or reduced their stakes in SGRY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Surgery Partners by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company’s stock worth $1,085,000 after purchasing an additional 2,015 shares during the last quarter. Millennium Management LLC increased its holdings in Surgery Partners by 1,253.7% in the first quarter. Millennium Management LLC now owns 202,274 shares of the company’s stock valued at $4,804,000 after purchasing an additional 219,806 shares during the period. Empowered Funds LLC lifted its holdings in Surgery Partners by 11.0% during the 1st quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock worth $305,000 after buying an additional 1,278 shares during the period. Prudential Financial Inc. acquired a new stake in shares of Surgery Partners in the second quarter valued at about $219,000. Finally, Invesco Ltd. increased its stake in shares of Surgery Partners by 7.4% in the 2nd quarter. Invesco Ltd. now owns 1,683,311 shares of the company’s stock valued at $37,420,000 after acquiring an additional 115,627 shares in the last quarter.

Surgery Partners News Summary

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Q2 results beat expectations: Adjusted earnings were $0.10 per share versus the $0.06 consensus estimate, while revenue of $848.9 million exceeded the $830.0 million forecast. Revenue increased 2.7% year over year, and same-facility revenue rose 5.0%. Surgery Partners Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Full-year guidance was reaffirmed: Surgery Partners continues to expect 2026 revenue of $3.35 billion to $3.45 billion and adjusted EBITDA of at least $530 million, excluding the pending Idaho Falls divestiture. Management said the transaction should improve cash conversion and support deleveraging. Surgery Partners Announces Second Quarter Results
• Positive Sentiment: Analyst support remains favorable: Cantor Fitzgerald reaffirmed its “overweight” rating and set an $18 price target. A separate brokerage consensus target was reported at $21.60, implying substantial potential upside from recent trading levels. Cantor Fitzgerald Reiterates Overweight Rating
• Neutral Sentiment: Broader healthcare stocks could benefit if weak employment data increases expectations for Federal Reserve interest-rate cuts, although this is a sector-wide factor rather than a Surgery Partners-specific catalyst. Likely ETF and Stock Winners From July Jobs Report
• Negative Sentiment: Profitability and cash generation weakened: Q2 net loss attributable to Surgery Partners widened to $15.0 million from $2.5 million a year earlier. Adjusted EBITDA declined to $125.2 million from $129.0 million, while operating cash flow fell to $59.3 million from $81.3 million. Net debt remained elevated at approximately 4.4 times EBITDA. Surgery Partners Reports Second Quarter Results

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.